Sidoti Csr Brokers Raise Earnings Estimates for USNA

USANA Health Sciences, Inc. (NYSE:USNA) – Analysts at Sidoti Csr upped their Q1 2025 earnings estimates for USANA Health Sciences in a research report issued on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will post earnings of $0.84 per share for the quarter, up from their prior estimate of $0.73. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2025 earnings at $0.74 EPS, Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $3.09 EPS and FY2026 earnings at $3.63 EPS.

Other equities research analysts also recently issued reports about the company. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday. DA Davidson raised shares of USANA Health Sciences to a “hold” rating in a report on Friday, December 20th.

USANA Health Sciences Stock Performance

NYSE:USNA opened at $35.69 on Friday. The stock has a market cap of $680.25 million, a price-to-earnings ratio of 12.61, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. USANA Health Sciences has a one year low of $31.44 and a one year high of $54.81. The business’s 50-day simple moving average is $37.88 and its 200 day simple moving average is $39.94.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.07. The firm had revenue of $200.22 million for the quarter, compared to analyst estimates of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same quarter in the previous year, the business posted $0.59 EPS.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Pzena Investment Management LLC raised its stake in USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after acquiring an additional 72,977 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of USANA Health Sciences by 0.6% during the second quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock valued at $30,907,000 after purchasing an additional 3,889 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after purchasing an additional 76,904 shares during the period. State Street Corp raised its position in shares of USANA Health Sciences by 0.6% during the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after purchasing an additional 2,782 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of USANA Health Sciences by 4.5% in the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock worth $11,269,000 after purchasing an additional 12,898 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.